Pretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.

Generic manufacturers are essential players in the fight to end TB so we do speak with generic manufacturers as part of our access strategy.

"High rates of treatment failure and deaths are associated with fluoroquinolone resistance in the Indian cohort of MDR-TB patients," stated...

The talks, which are in early stage, will allow Macleods to manufacture generic version of the drug, a move if goes through will improve ac...

Union Health Minister J P Nadda, in a written reply, said that the states are being prepared to monitor the treatment of patients with Beda...

In December 2016, the father of an 18-year-old patient suffering from XDR TB took National Institute of Tuberculosis and Respiratory Diseas...

LRS was responding to an affidavit asking whether the govt could provide the bedaquiline directly to the treating doctor instead of the pat...

"Patients need to be constantly monitored, which is why these centres are currently administering the drug only to residents of these six s...

The drugs –– Bedaquiline by US drugmaker J&J and Delamanid by Japanese drugmaker Otsuka Pharma –– are the only treatment option for patient...

Four of the six drugs given to patients with MDR-TB under the RNTCP could be ineffective in nearly 70% of patients, a study by Mumbai's Hin...

A ‘miracle drug’ to battle multi-drug resistant tuberculosis MDR-TB, and extensively-drug resistant TB (XDR-TB), will be rolled out on Mond...

Here's why drug-resistant tuberculosis (TB) breeds freely in Mumbai: Patients don't get appropriate medication.

Government officials say there are several reasons for this: bedaquiline is technically still in a trial phase and its cost in some high-in...

Vardhan said that an email repository will be built up for establishing connectivity between govt & all doctors in the country to help figh...

March 24 is World TB day. It commemorates the discovery of Tuberculosis (TB) bacillus in 1883 by Dr Robert Koch as the cause of tuberculosi...

Countries like India and China, with high numbers of TB cases could gain more from the money they spend on diagnosis and treatment of the d...

India has a major health challenge on its hands, figuring second on the list of countries with the largest concentration of people sufferin...